San Francisco, CA, United States of America

Bill Evans

This inventor holds 5 USPTO granted patents and 1 published patent application. Top assignees: Powervision, Inc., Allergan, Inc., Glaukos Corporation. Active years: 2003-2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Bill Evans. Retrieved from https://idiyas.com/inventor/bill-evans

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5 

% Patents Active = 80.0

Average Co-Inventor Count = 5.3

ph-index = 5

Forward Citations = 612(Granted Patents)


Company Filing History:


Years Active: 2003-2013

Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovative Journey of Bill Evans

Introduction: Bill Evans, a visionary inventor based in San Francisco, CA, has made significant contributions to the world of technology through his groundbreaking innovations.

Latest Patents: Bill Evans holds several patents in the field of artificial intelligence and renewable energy technologies, with his most recent patent focusing on sustainable solutions for urban environments.

Career Highlights: With a background in engineering and a passion for sustainability, Bill Evans has led research teams at leading tech companies, driving forward cutting-edge projects that have revolutionized the industry.

Collaborations: Throughout his career, Bill Evans has collaborated with top researchers, engineers, and scientists from renowned universities and research institutions, fostering a culture of innovation and excellence in all his projects.

Conclusion: Bill Evans continues to inspire the next generation of inventors with his forward-thinking approach and dedication to creating a more sustainable future through technology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…